Percutaneous transhepatic portal embolization using foam ethanolamine oleate and carbon dioxide (CO2): a clinical study

Research Project

Project/Area Number	25861111
Research Category	Grant-in-Aid for Young Scientists (B)
Allocation Type	Multi-year Fund
Research Field	Radiation science
Research Institution	Kumamoto University
Principal Investigator	Nakasone Yutaka 熊本大学, 医学部附属病院, その他 (50530151)
Research Collaborator	YAMASHITA Yasuyuki KAWANAKA Koichi IKEDA Osamu BEPPU Toru
Project Period (FY)	2013-04-01 – 2016-03-31
Project Status	Completed (Fiscal Year 2015)
Budget Amount *help	¥3,250,000 (Direct Cost: ¥2,500,000、Indirect Cost: ¥750,000) Fiscal Year 2015: ¥910,000 (Direct Cost: ¥700,000、Indirect Cost: ¥210,000) Fiscal Year 2014: ¥910,000 (Direct Cost: ¥700,000、Indirect Cost: ¥210,000) Fiscal Year 2013: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Keywords	経皮経肝的門脈塞栓術 / 泡沫化硬化剤 / オルダミン / 泡沫硬化剤
Outline of Final Research Achievements	Percutaneous transhepatic portal embolization (PTPE) can induce atrophy of the embolized- and hypertrophy of the residual area. These effects are advantageous in patients scheduled for extended hepatectomy. To evaluate the experimental clinical safety and effectiveness of foam sclerotherapy with foam ethanolamine oleate (EO) and carbon dioxide (CO2) for PTPE. Sclerotherapy using foam EOI and CO2 is clinically safe and effective for PTPE before hepatectomy.

Report

(4 results)